Donor myocardial HIF-1α is an independent predictor of cardiac allograft dysfunction: A 7-year prospective, exploratory study

American Journal of Transplantation

Volumn 7, Issue 8, 2007, Pages 2012-2019

  Aharinejad, S ^a,b   Schafer R ^b   Krenn, K ^a,b   Zuckermann, A ^a   Schneider, B ^a   Neumann, F ^a   Paulus, P ^b   Wieselthaler, G ^a   Wolner, E ^a   Grimm, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Medical University of Vienna   (Austria)

Author keywords

Heart transplantation; HIF 1 ; Marker; Primary graft dysfunction

Indexed keywords

BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; NAB 2 PROTEIN; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN A;

ADULT; AORTA CLAMPING; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE MARKER; DNA MICROARRAY; FEMALE; HEART DILATATION; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART TRANSPLANTATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNIVARIATE ANALYSIS;

BIOLOGICAL MARKERS; BIOPSY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; MYOCARDIUM; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34447120166     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01875.x     Document Type: Article

References (20)

1. Taylor DO, Edwards LB, Mohacsi PJ et al. The registry of the International Society for Heart and Lung Transplantation: Twentieth official adult heart transplant report-2003. J Heart Lung Transplant 2003 22 : 616 624.
2. Rodeheffer RJ, Naftel DC, Stevenson LW et al. Secular trends in cardiac transplant recipient and donor management in the United States. Circulation 1996 94 : 2883 2889.
3. Young JB, Naftel DC, Bourge RC et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: A multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant 1994 13 : 353 365.
4. Suzuki K, Murtuza B, Smolenski RT et al. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 2001 104 : I308 I313.
5. Szabo G, Stumpf N, Radovits T et al. Effects of inosine on reperfusion injury after heart transplantation. Eur J Cardiothorac Surg 2006 30 : 96 102.
6. Jiang B, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996 271 : 17771 17778.
7. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000 275 : 26765 26771.
8. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999 94 : 1561 1567.
9. Gorlach A, Diebold I, Schini-Kerth VB et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 2001 89 : 47 54.
10. Kumbrink J, Gerlinger M, Johnson JP. Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop. J Biol Chem 2005 280 : 42785 42793.
11. Costanzo MR, Augustine S, Bourge R et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995 92 : 3593 3612.
12. Aharinejad S, Krenn K, Paulus P et al. Differential role of TGF-beta1/bFGF and ET-1 in graft fibrosis in heart failure patients. Am J Transplant 2005 5 : 2185 2192.
13. Marasco SF, Esmore DS, Negri J et al. Early institution of mechanical support improves outcomes in primary cardiac allograft failure. J Heart Lung Transplant 2005 24 : 2037 2042.
14. Taghavi S, Zuckermann A, Ankersmit J et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg 2004 78 : 1644 1649.
15. Schafer R, Abraham D, Paulus P et al. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Circulation 2003 108 : 1585 1591.
16. Oz MC, Liao H, Naka Y et al. Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. Circulation 1995 92 : II428 II432.
17. Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA 3rd. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res 2006 98 : 133 140.
18. Piret JP, Mottet D, Raes M, Michiels C. Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 2002 64 : 889 892.
19. Chi NC, Karliner JS. Molecular determinants of responses to myocardial ischemia/reperfusion injury: Focus on hypoxia-inducible and heat shock factors. Cardiovasc Res 2004 61 : 437 447.
20. Keranen MA, Nykanen AI, Krebs R et al. Effect of graft preservation and acute rejection on hypoxia-inducible factor-1 in rat cardiac allografts. Transplant Proc 2006 38 : 3372 3373.